Press releaseBusiness Wire
Conmed
CNMD · NYSE
$47.58+$1.53 (+3.32%)TodayMarket closed ·
Prev close $46.05
Latest news
- Press releaseBusiness Wire
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
- Press releaseBusiness Wire
CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
- Press releaseBusiness Wire
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal® Robotic Solution for Use with the Intuitive da Vinci 5 Hex Cannula
- Press releaseBusiness Wire
CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting
- Press releaseBusiness Wire
CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026
- Press releaseBusiness Wire
CONMED Corporation Appoints John E. Gallagher as Chief Financial Officer
- Press releaseBusiness Wire
CONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of Directors
- News
Conmed Q1 Adj. EPS $0.89 Beats $0.82 Estimate, Sales $317.046M Beat $310.507M Estimate
- Press releaseBusiness Wire
CONMED Corporation Announces First Quarter 2026 Financial Results
- News
Earnings Scheduled For April 29, 2026
- Press releaseBusiness Wire
CONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026
- News
What Analysts Are Saying About Conmed Stock
- Press releaseBusiness Wire
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results
- News
Earnings Scheduled For January 28, 2026
- News
A Glimpse of Conmed's Earnings Potential
- Press releaseBusiness Wire
CONMED Corporation Announces Chief Financial Officer Transition
- Press releaseBusiness Wire
CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Press releaseBusiness Wire
CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026
- NewsVandana Singh
Conmed Dumps Gastroenterology Business To Focus On Core Surgical Markets
- Press releaseBusiness Wire
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
- Press releaseBusiness Wire
CONMED Corporation Announces Third Quarter 2025 Financial Results
- Press releaseBusiness Wire
CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025
- Press releaseBusiness Wire
CONMED Corporation Adds Kim Kelderman to its Board of Directors
- Press releaseBusiness Wire
CONMED Corporation Announces Quarterly Cash Dividend
- Press releaseBusiness Wire
CONMED Corporation Announces Second Quarter 2025 Financial Results
- Press releaseBusiness Wire
Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.
- Press releaseBusiness Wire
CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025
- News
Demystifying Conmed: Insights From 5 Analyst Reviews
- Press releaseBusiness Wire
CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors
- Press releaseBusiness Wire
CONMED Corporation Announces Quarterly Cash Dividend
- NewsAvi Kapoor
CVS Health Posts Better-Than-Expected Earnings, Joins CommScope, Microsoft, Meta, Chart Industries, And Other Big Stocks Moving Higher On Thursday
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
Breaking Down Conmed: 6 Analysts Share Their Views
- Press releaseBusiness Wire
CONMED Corporation Announces Leadership Succession
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.